What percent of ANVS is sold short?

57.9% of Annovis Bio (ANVS) trading volume was short last week. Track days-to-cover and borrow rate against insider and hedge fund flow.

Is ANVS a short squeeze candidate?

Compare short volume, days-to-cover, and borrow rate to insider buying — when insiders accumulate against heavy short interest, the squeeze setup gets stronger.

How is short volume different from short interest?

Short volume is daily shorting activity reported by FINRA; short interest is the bi-monthly snapshot of outstanding short positions. We track both for Annovis Bio (ANVS).

ANVS Short Volume Hit 57.9%

$1.18

+0.01 (+0.85%)

Weekly Expected Move ±10.6%

$1 $1 $1 $1 $1

NYSE · Healthcare · Biotechnology · Tech Score Sell · Power 33 · $50.2M mcap · 38M float · 2.56% daily turnover · Short 59% of daily vol

Short Volume Summary

2026-10-01

44.1%

Short Ratio

of total volume

64.0%

20-Day Avg

57.4%

50-Day Avg

▼ Falling

5-Day Trend

0.3M

Short Volume

0.6M

Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-01

Exchange	Short Volume	Total Volume	Short %
NASDAQ	274,728	630,506	43.6%
NYSE	7,170	8,479	84.6%
BATS	200	200	100.0%

ANVS Short Interest

Short Volume Summary

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

Sign in to InsiderStreet